|
RERE expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.59909929321157E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.82005538313024E-12 |
| Normal-vs-Stage2 |
1.221220E-04 |
| Normal-vs-Stage3 |
1.56074999999589E-05 |
| Normal-vs-Stage4 |
7.55569999899564E-08 |
| Stage1-vs-Stage2 |
7.768800E-01 |
| Stage1-vs-Stage3 |
8.917400E-01 |
| Stage1-vs-Stage4 |
2.420400E-01 |
| Stage2-vs-Stage3 |
7.594600E-01 |
| Stage2-vs-Stage4 |
2.346200E-01 |
| Stage3-vs-Stage4 |
3.768000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.01689775991554E-11 |
| Normal-vs-AfricanAmerican |
1.84410264836288E-11 |
| Normal-vs-Asian |
6.04719999630632E-08 |
| Caucasian-vs-AfricanAmerican |
1.326200E-01 |
| Caucasian-vs-Asian |
9.645900E-02 |
| AfricanAmerican-vs-Asian |
1.193590E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.40985009725136E-12 |
| Normal-vs-Female |
3.64640000000138E-05 |
| Male-vs-Female |
7.547800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.33579999576028E-08 |
| Normal-vs-Extreme_Weight |
1.66866520601161E-13 |
| Normal-vs-Obese |
9.20209997090637E-09 |
| Normal-vs-Extreme_Obese |
5.77200000018152E-08 |
| Normal_Weight-vs-Extreme_Weight |
4.130200E-01 |
| Normal_Weight-vs-Obese |
6.022400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.777000E-01 |
| Extreme_Weight-vs-Obese |
1.160020E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.290000E-01 |
| Obese-vs-Extreme_Obese |
3.150000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.017800E-03 |
| Normal-vs-Age(41-60Yrs) |
7.90969956199206E-10 |
| Normal-vs-Age(61-80Yrs) |
1.93922655711276E-12 |
| Normal-vs-Age(81-100Yrs) |
7.24980000033071E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.650800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.000800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.442400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.990300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.801600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.886000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.76454423189898E-12 |
| Normal-VS-Type2 PRCC |
7.88429987963468E-10 |
| Normal-VS-KIRP CIMP |
4.859100E-03 |
| Normal-VS-Unclassified PRCC |
9.968800E-04 |
| Type1 PRCC-VS-Type2 PRCC |
9.408200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.338200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.033000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.210200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.328400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.653000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.67599950479303E-10 |
| Normal-vs-N1 |
3.77859999955987E-07 |
| Normal-vs-N2 |
6.486300E-02 |
| N0-vs-N1 |
4.874000E-01 |
| N0-vs-N2 |
2.656200E-01 |
| N1-vs-N2 |
1.953020E-01 |
|
|
